Crinetics Pharmaceuticals, Inc.
XNAS:CRNX
45.32
$45.41 - 131.00
$45.31 - 42.00
$44.6
$46.04
$45.25
$45.25
60.34
24.1
333643
1194479.1
88180862.12
Chart
TendieTensor AI Analysis
Company
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Fundamentals
437
-9.980000
3.990320
-1.38
100
BBG00BC59224
BBG00BC592C3
94.18M
94.89M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CRNX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.